PT UBC Medical Indonesia Tbk Stock

Equities

LABS

ID1000205305

Medical Equipment, Supplies & Distribution

End-of-day quote INDONESIA S.E. 06:00:00 2024-07-14 pm EDT 5-day change 1st Jan Change
170 IDR -13.27% Intraday chart for PT UBC Medical Indonesia Tbk 0.00% 0.00%
Sales 2022 93.29B 5.78M Sales 2023 137B 8.48M Capitalization 774B 47.97M
Net income 2022 2.83B 176K Net income 2023 2.19B 136K EV / Sales 2022 * -
Net cash position 2022 * - 0 Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 64
Yield 2022 *
-
Yield 2023 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 week
137.00
Extreme 137
228.00
1 month
137.00
Extreme 137
228.00
Current year
137.00
Extreme 137
228.00
1 year
137.00
Extreme 137
228.00
3 years
137.00
Extreme 137
228.00
5 years
137.00
Extreme 137
228.00
10 years
137.00
Extreme 137
228.00
More quotes
Date Price Change Volume
24-07-15 170 -13.27% 172,524,900
24-07-12 196 +6.52% 284,796,600
24-07-11 184 +34.31% 381,208,500

End-of-day quote INDONESIA S.E., July 14, 2024

More quotes
PT UBC Medical Indonesia Tbk is an Indonesia-based medical diagnostic company. The Company provides affordable medical diagnostic tests and instruments for the Indonesian healthcare market. The Company operates through two segments: Medical disposable and consumables, and Diagnostic and equipment. It offers various products to detect and diagnose various diseases, such as tuberculosis, cervical cancer, newborn screening, COVID-19, health risk screening with artificial intelligence (AI) and molecular systems. Its products include NeoMoDX Molecular System, Airdoc, QIAstat-DX Analyzer, Care HPV System, Hybrid Capture 2 - HPV DNA Test, Revvity SARS-COV-2 RT PCR, Geneproof SARS-COV-2 PCR KIT, Quantiferon TB Gold Plus, Genoscholar, Ina TB, GSP Neonatal Kit, Delfia Neonatal Kit, Neonatal Sampling Paper and Victor2 D.
More about the company